Impax Laboratories Confirms Patent Challenge Relating to ORACEA Delayed-Release Capsules, 40mg

Sep 21, 2009 - Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by Galderma Laboratories, L.P. in connection with its ORACEA® (doxycycline) delayed-release capsules, 40 mg.

The details can be read here.